Submission Details
| 510(k) Number | K053031 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 27, 2005 |
| Decision Date | December 07, 2005 |
| Days to Decision | 41 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
K053031 is an FDA 510(k) clearance for the EXTENDSURE HBFASC CONTROL, a Control, Hemoglobin, Abnormal (Class II — Special Controls, product code JCM), submitted by Cantebury Scientific , Ltd. (Christchurch, Canterbury, NZ). The FDA issued a Cleared decision on December 7, 2005, 41 days after receiving the submission on October 27, 2005. This device falls under the Hematology review panel. Regulated under 21 CFR 864.7415.
| 510(k) Number | K053031 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 27, 2005 |
| Decision Date | December 07, 2005 |
| Days to Decision | 41 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
| Product Code | JCM — Control, Hemoglobin, Abnormal |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 864.7415 |